
Late Line Therapy in Multiple Myeloma Dr. Jason Chandler discussed the management of what he calls “penta-refractory” multiple myeloma (MM) patients and the available treatment options at the 2023 West Oncology Conference. He shared that relapsed or refractory #MultipleMyeloma is an incurable diagnosis, but thankfully one with an increasing number of treatment options. Providers should… Read more »